genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • GEN Edge
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
    • Videos
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Eye Disorders

      Prime Editing Reverses Vision Loss in Mice

      3D illustration Rendering of binary code pattern.Futuristic Particles digital Landscape wave Abstract background for business,Science and technology
      Artificial Intelligence

      AI-Proofing Workflows in Drug Development

      Lung Cancer
      Cancer

      New Drug Combo Reduces Lung Tumors in Mice

      Corn crop
      AgBio

      Gene Discovery May Help Effort to Breed Climate Resilient Crops

      RNA strands consisting of nucleotides important for protein bio-synthesis
      Cancer

      Novel Approach Delivers Therapeutic RNA Molecules to Selectively Target Cells

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      Abstract Colorful Blue Radial Glitch Chromatic Holographic Background
      Cancer

      Lightspeed’s Jonathan MacQuitty and the Laws of Biotech Relativity

      scientists workin
      Biologics

      Biologics Manufacturing without the Cells

      Bioprocessing

      Bio-Inspired Coatings Could Make Cell Activation More Efficient in Therapy Production

      Bioprocessing

      Vortex-Focusing Microfluidics Yields Precisely Sized Liposomes at Scale

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • GEN Edge
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
    • Videos
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home Companies Illumina

Illumina

  • 23andMe
  • Abbvie
  • AdnaGen
  • Agilent Technologies
  • Alexion Pharmaceuticals
  • Amgen
  • Astellas
  • AstraZeneca
  • Audentes Therapeutics
  • Berkeley Lights
  • Bio-Rad Laboratories
  • Biogen
  • Cancer Genetics
  • Catalent
  • Charles RIver Laboratories
  • Dana-Farber Cancer Institute
  • deCODE genetics
  • Dicerna
  • Dimension Therapeutics
  • Exact Sciences
  • Foundation Medicine
  • GE Healthcare
  • GeneInsight
  • Gilead Sciences
  • GlaxoSmithKline
  • Halozyme Therapeutics
  • Hitachi High-Technologies
  • Horizon Discovery Group
  • Human Longevity
  • Illumina
  • Jackson Laboratory
  • Janssen Biotech
  • LabCorp
  • Maravai LifeSciences
  • MD Anderson
  • MDxHealth
  • MedImmune
  • Memorial Sloan Kettering Cancer Center
  • Merck & Co
  • Merck KGaA
  • NanoString Technologies
  • Novartis
  • Pathology
  • PerkinElmer
  • PersonalizeDx
  • Qiagen
  • RayBiotech
  • Roche
  • Sanofi
  • shire
  • Sigma-Aldrich
  • Synthego
  • Takeda
  • Thermo Fisher Scientific
  • UCB Biosciences
    Latest
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Liquid Biopsies

    StockWatch: Icahn Pursues Illumina Board Seats, and a Sell-Off of Grail

    Next-Generation Sequencing

    StockWatch: Analysts Mixed on Illumina after Q4 Results, Delivery of First NovaSeq X Plus System

    Financing

    EY Eyes Comeback for Biopharma M&A

    Whole-Genome Analysis

    At JPM, Illumina Announces African-American Sequencing Collaboration

    Alzheimers

    StockWatch: Analysts Sour on Roche after Alzheimer’s Clinical Failure

    Illumina

    Illumina Reveals New High-Throughput Instrument, NovaSeq X

    Barack Obama DNA Illumina Genomics Forum
    Illumina

    At Illumina Genomics Forum, Obama Prescribes Diversity, Resilience to Drive Precision...

    Illumina

    Illumina Predictions: What Will They Reveal at This Week’s Forum?

    Illumina

    StockWatch: Illumina Bounces Back After FTC Win, EU Loss

    Illumina

    Judge Sides with Illumina, Rejecting FTC Challenge to Grail Deal

    Next-Generation Sequencing

    X Marks the $100 Genome: Illumina Presents New Chemistry, Strong Results

    Next-Generation Sequencing

    Fast and Flexible: Singular’s G4 Takes Aim at Illumina’s Sequencing Superiority

    Sequencing

    Introducing “Close to the Edge”: A Zoom Conversation with PacBio CEO...

    Illumina

    Illumina Vows to Fight Back as FTC Takes Aim at $8B...

    Beautiful Korean woman with cancer smiles at doctor
    Illumina

    Illumina Launching Pan-Cancer IVD Test, Cloud-Based Bioinformatics Platform

    123Page 1 of 3

    Recently Featured

    Prime Editing Reverses Vision Loss in Mice

    Prime Editing Reverses Vision Loss in Mice

    AI-Proofing Workflows in Drug Development

    AI-Proofing Workflows in Drug Development

    Gene Discovery May Help Effort to Breed Climate Resilient Crops

    Gene Discovery May Help Effort to Breed Climate Resilient Crops

    Novel Approach Delivers Therapeutic RNA Molecules to Selectively Target Cells

    Novel Approach Delivers Therapeutic RNA Molecules to Selectively Target Cells

    Read the Digital Edition

    Explore

    • About GEN
    • Contact GEN
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • Inside Precision Medicine
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up